LYMPHADENOPATHY ON CT SCAN. COMPARED WITH MEDIASTINOSCOPY

Node, the 22-gauge needle is passed through the bronchial wall
and that into the lymph node once the outer sheath has been positioned
and brought in contact with the airway. the balloon is
deflated prior to deployment of the needle to forestall balloon
rupture. the needle is passed back and forth through the lymph
node once a vacuum syringe has been connected to the needle
so as to aspirate lymphatic tissue either within the sort of cells or
actual tissue cores.
ebus-tbna may be a promising various to mediastinoscopy
for the staging of mln in patients who present with mediastinal
lymphadenopathy on ct scan. compared with mediastinoscopy,
ebus-tbna is less invasive, are often performed beneath conscious
sedation ( as opposed to general anesthesia ), and doesn't require
overnight hospitalization ( less costly ). additional importantly,
ebus-tbna allows access to posterior subcarinal, seven hilar, ten and
intrapulmonary ( 11 ) lymph nodes, that are inaccessible by
mediastinoscopy. additionally, unlike mediastinoscopy, ebus-tbna
are often performed multiple times on identical patient without
deleterious impact, all whereas preserving the integrity of the mediastinum.
this may be an necessary reality if future mediastinal restaging
may be anticipated, as is usually the case with stage iiia-n2 disease following
induction chemotherapy. a recent study by herth et al. 46
investigated the ability of ebus-tbna to accurately restage the
mediastinum following induction chemotherapy in patients
with stage iiia-n2 non–small cell lung cancer ( nsclc ).
between february 2003 and march 2006, 124 patients who had
completed induction chemotherapy, underwent ebus-tbna,
followed by thoracotomy with resection and systematic lymph
node operation with curative intent. the sensitivity, specificity,
positive predictive price ( ppv ), npv, and diagnostic accuracy
of ebus-tbna were 76%, 100%, 100%, 20%, and 77%, respectively.
these results compare favorably with those observed
in studies that have performed remediastinoscopy 47–50 or eustna
51, 52 within the mediastinal restaging of similar cohorts.
within the largest study revealed to date on ebus-tbna
sampling of mln, herth et al. 53 biopsied 572 enlarged ( 1 cm
on ct ) lymph nodes from 502 patients, between june 2002
and september 2004. the average lymph node size as measured
throughout ebus examination was one. vi cm. ( vary zero. eight to three. a pair of ).
ebus-tbna established a diagnosis in 535 of the 572 lymph
nodes biopsied, providing a diagnostic yield of 93. 5%. on a
per patient basis, a diagnosis was obtained in 470 of 502 patients,
establishing a diagnostic yield of 93%. overall, ebustbna
had a sensitivity, specificity, accuracy, ppv, and npv
of 94%, 100%, 94%, 100%, and 11%, respectively. given the
low npv, that reflects a high variety of false negatives, the
authors have prompt that a negative ebus-tbna be followed
by a additional definitive diagnostic procedure, presumably,
a mediastinoscopy.
current guidelines for the noninvasive staging of nsclc
recommend that a pet scan be administered to any patient
with clinical stage ia to iiib disease that's being treated with
curative intent. 54
moreover, it's recommended that any abnormal ( positive
standardized uptake price suv ) lymph nodes on fdg-pet
ought to be more evaluated via tissue sampling. the question
then becomes, “what procedure ought to be performed to get
tissue samples from pet-positive lymph nodes ?” a recent
study evaluated the use of real-time ebus-tbna for the sampling
of pet-positive lymph nodes in 106 patients with proven
( 29 patients ) or suspected ( 77 patients ) lung cancer. 55
all procedures were done beneath conscious sedation, and
patients were managed on an outpatient basis. based mostly on the 90
assessable patients, the sensitivity, specificity, ppv, npv, and
accuracy of ebus-tbna for pet-positive lymph node staging
were 93%, 100%, 100%, 91%, and 97%. furthermore,
surgical intervention was avoided by the use of ebus-tbna
in 56% ( 59 of 106 ) of the patients. in experienced hands,
these findings recommend that ebus-tbna ought to be considered
because the initial technique of sampling in patients with suspected/
proven lung cancer and pet-positive lymph nodes. in spite of this,
subsequent surgical sampling ought to be performed following a
negative ebus-tbna, based mostly on a 10% false-negative ebustbna
rate. lastly, at the time of procedure, ebus-tbna
additionally allows the sampling of any pet-normal mln that are
visualized. this provides a straightforward suggests that to rule out occult
n2/n3 disease. ebus-tbna found lymph node metastasis
in pet-negative nodes in four of 58 positive patients, upstaging
these patients from suspected n1 and n2 based mostly on pet, to n2
and n3, respectively.
information exist, that demonstrate that a major percentage
of nsclc patients with clinical stage i disease do, actually,
harbor lymph node metastases. anywhere between 15% to
37% of patients with negative lymph nodes on ct scan are
found to haven't anydal involvement upon surgical staging, 56 depending
on what information is referenced. 57–60 this may be a reflection
of the low sensitivity and accuracy of ct scan in staging the
mediastinum in lung cancer patients. this proportion drops to
9% to 11% in patients with solely t1 lesions. 61, 62
even at this lower estimation, mln staging prior to
surgical intervention in clinical stage i nsclc patients is
justified. between january 2003 and march 2005, herth
et al. 63 evaluated ebus-tbna as a suggests that of sampling
lymph nodes in nsclc patients with ct scans showing
no enlarged lymph nodes ( no node 1 cm ) within the mediastinum.
in 100 patients, 119 lymph nodes between five to
ten mm were sampled, with a mean diameter of eight. one mm.
ebus-tbna correctly identified nineteen out of 21 lymph
node–positive patients and all 79 lymph node–negative patients.
of the nineteen positive cases identified by ebus-tbna,
three had n3 disease, thirteen had n2 disease, and three had n1 disease.
sensitivity, specificity, and npv of ebus-tbna were
92. 3%, 100%, and ninety six. 3%, respectively. these findings suggest
that ebus-tbna are often used as an correct thanks to
preoperatively stage the mediastinum in nsclc patients
with normal-appearing lymph nodes, a procedure, that in
the past was merely reserved on behalf of mediastinoscopy.
as a result of the very fact that pet scan is currently being incorporated
into the normal workup on lung cancer patients,
ebus-tbna has additionally been evaluated as a suggests that of staging the
mediastinum in nsclc patients with a ct and pet-normal
mediastinum.